Release Form
Injection pen
Indications for using MyStart Weight Loss
Supports medically supervised weight loss in adults with obesity or overweight conditions. Combines FDA-approved GLP-1 medication with dietary and lifestyle guidance for sustainable results. Clinical studies show up to 20% body weight reduction over 68 weeks when used consistently.
Sale Conditions
Sale requires medical consultation and prescription approval through telehealth evaluation.
Volume/Unit in Package
3 ml
Storage Conditions
Store refrigerated at 2°C–8°C (36°F–46°F). Protect from light and avoid freezing.
Shelf Life
24 months from manufacturing date
Active Principles of MyStart Weight Loss
Instructions for Using MyStart Weight Loss
1
2
3
Known Side Effects
Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and constipation. Rare cases of pancreatitis or allergic reactions have been reported. Discontinue use if severe side effects occur.
Contraindications
Not suitable for pregnant or breastfeeding women. Not recommended for individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Consult a doctor if you have allergies or existing medical conditions.
No reviews yet
